Al-Ahmad, A., Mittal, S., Delurgio, D., Joseph Gallinghouse, G., Horton, R.p., Preminger, M.w., et al. (2021). Results from the prospective, multicenter AMBULATE-CAP trial: Reduced use of urinary catheters and protamine with hemostasis via the Mid-Bore Venous Vascular Closure System (VASCADE® MVP) following multi-access cardiac ablation procedures. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 32(2), 191-199 [10.1111/jce.14828].
Results from the prospective, multicenter AMBULATE-CAP trial: Reduced use of urinary catheters and protamine with hemostasis via the Mid-Bore Venous Vascular Closure System (VASCADE® MVP) following multi-access cardiac ablation procedures
Natale A.
2021-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
